NCT00941278View on ClinicalTrials.gov

An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

April 30, 2010

Conditions
Psoriasis
Interventions
DRUG

PH-10 (0.001% Rose Bengal)

PH-10 will be applied daily for 28 days to skin areas affected by mild to moderate psoriasis.

Trial Locations (2)

10029

Mount Sinai School of Medicine, New York

33144

International Dermatology Research, Miami

Sponsors
All Listed Sponsors
lead

Provectus Pharmaceuticals

INDUSTRY